January 15, 2020
Astellas Pharma and Adaptimmune Therapeutics said on January 14 that they have sealed a pact for the codevelopment and cocommercialization of new stem cell-derived allogeneic T-cell therapies for the treatment of cancer. Under the deal, which was concluded between Universal...read more